Advertisement
Advertisement

INTS

INTS logo

Intensity Therapeutics, Inc. Common stock

0.37
USD
Sponsored
-0.01
-1.36%
Jan 30, 15:57 UTC -5
Closed
exchange

After-Market

0.37

0.00
+0.81%

INTS Earnings Reports

Positive Surprise Ratio

INTS beat 6 of 10 last estimates.

60%

Next Report

Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
Implied change from Q3 25 (Revenue/ EPS)
--
/
--
Implied change from Q-- -- (Revenue/ EPS)
--
/
--

Intensity Therapeutics, Inc. Common stock earnings per share and revenue

On Nov 06, 2025, INTS reported earnings of -0.06 USD per share (EPS) for Q3 25, beating the estimate of -0.08 USD, resulting in a 32.81% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -6.22% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
FAQ
For Q3 2025, Intensity Therapeutics, Inc. Common stock reported EPS of -$0.06, beating estimates by 32.81%, and revenue of $0.00, 0% as expectations.
The stock price moved down -6.22%, changed from $0.49 before the earnings release to $0.46 the day after.
The next earning report is scheduled for --.
Based on -- analysts, Intensity Therapeutics, Inc. Common stock is expected to report EPS of -- and revenue of -- for Q-- --.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement